article thumbnail

ISPE’s Regulatory Commenting Process

ISPE

After a thorough internal review, health authorities sometime release a document for public comment. Regulations, draft guidance, and other documents may be requested for public comment. ISPE utilizes its members' expertise and knowledge to provide official comments on government documents. Offer helpful solutions.

article thumbnail

PDA revises report on glass container manufacturing

European Pharmaceutical Review

Having been originally published in 2007, then revised in 2013, this latest 2023 edition addresses evolving standards and container types. Specifically, the document covers the development process of glass containers for pharmaceutical products, glass container sampling as well as definition of lots.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Professional Standards for Homecare Services updated by RPS

Hospital Pharmacy Europe

Originally published in 2013 , the standards aim to ensure consistent, high-quality care for patients receiving medicines and associated services in their own homes that would previously have been supplied in hospitals. ‘As

article thumbnail

Heart Failure Guideline Updates in 2021

Med Ed 101

There are a few important heart failure guideline updates in the works to the American College of Cardiology’s Heart Failure Guidelines, last published in 2013. This document […]. The post Heart Failure Guideline Updates in 2021 appeared first on Med Ed 101.

article thumbnail

Novartis agrees $245m settlement over Exforge generics delay

pharmaphorum

The FDA granted full approval to Par’s generic on 28 March, 2013. According to court documents cited by Reuters, annual sales of Exforge in the US were over $400 million before generic versions reached the market.

article thumbnail

Building a better future for people with rare diseases in all four UK nations

pharmaphorum

Published in January, the document replaces 2013’s UK Strategy for Rare Diseases and sets out four priorities for the next five years: faster diagnosis, increasing awareness among healthcare professionals, the better coordination of care, and improving access to specialist care, treatments, and drugs.

article thumbnail

NHS data sharing scheme “on hold” as millions opt out

pharmaphorum

The debacle conjures up the spectre of the government’s last attempt to shake up patient data-sharing – 2013’s Care.data scheme – which suffered from a number of false starts and was eventually shut down in 2016. survey conducted in July. ” The post NHS data sharing scheme “on hold” as millions opt out appeared first on.